Search research articles
Contact Us
Filters
Showing results (71-80 of 132) with videos related to
Page
of 14
Sort By:
Journal of Molecular and Cellular Cardiology
|
July 31, 2013
Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice
Andrea Stöhr, Felix W Friedrich, Frederik Flenner, et al.
Journal of Molecular and Cellular Cardiology
|
January 31, 2015
Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology
Marc N Hirt, Tessa Werner, Daniela Indenbirken, et al.
Cardiovascular Research
|
October 11, 2019
Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissue
Marta Lemme, Ingke Braren, Maksymilian Prondzynski, et al.
Journal of Molecular and Cellular Cardiology
|
February 14, 2021
Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes
Alexandra Madsen, Julia Krause, Grit Höppner, et al.
Tissue Engineering. Part A
|
October 26, 2013
In vitro perfusion of engineered heart tissue through endothelialized channels
Ingra Vollert, Moritz Seiffert, Johanna Bachmair, et al.
Stem Cells Translational Medicine
|
May 8, 2015
Immunobiology of fibrin-based engineered heart tissue
Lenard Conradi, Stephanie Schmidt, Evgenios Neofytou, et al.
Stem Cell Reports
|
November 13, 2018
Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human Atrium
Marta Lemme, Bärbel M Ulmer, Marc D Lemoine, et al.
Basic Research in Cardiology
|
October 27, 2012
Increased afterload induces pathological cardiac hypertrophy: a new in vitro model
Marc N Hirt, Nils A Sörensen, Lena M Bartholdt, et al.
Molecular Therapy. Nucleic Acids
|
June 19, 2017
Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes
Maksymilian Prondzynski, Elisabeth Krämer, Sandra D Laufer, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
April 29, 2017
Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae
Ingra Mannhardt, Alexandra Eder, Berengere Dumotier, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 132) with videos related to
Sort By:
Page
of 14
Journal of Molecular and Cellular Cardiology
|
July 31, 2013
Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice
Andrea Stöhr, Felix W Friedrich, Frederik Flenner, et al.
Journal of Molecular and Cellular Cardiology
|
January 31, 2015
Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology
Marc N Hirt, Tessa Werner, Daniela Indenbirken, et al.
Cardiovascular Research
|
October 11, 2019
Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissue
Marta Lemme, Ingke Braren, Maksymilian Prondzynski, et al.
Journal of Molecular and Cellular Cardiology
|
February 14, 2021
Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes
Alexandra Madsen, Julia Krause, Grit Höppner, et al.
Tissue Engineering. Part A
|
October 26, 2013
In vitro perfusion of engineered heart tissue through endothelialized channels
Ingra Vollert, Moritz Seiffert, Johanna Bachmair, et al.
Stem Cells Translational Medicine
|
May 8, 2015
Immunobiology of fibrin-based engineered heart tissue
Lenard Conradi, Stephanie Schmidt, Evgenios Neofytou, et al.
Stem Cell Reports
|
November 13, 2018
Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human Atrium
Marta Lemme, Bärbel M Ulmer, Marc D Lemoine, et al.
Basic Research in Cardiology
|
October 27, 2012
Increased afterload induces pathological cardiac hypertrophy: a new in vitro model
Marc N Hirt, Nils A Sörensen, Lena M Bartholdt, et al.
Molecular Therapy. Nucleic Acids
|
June 19, 2017
Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes
Maksymilian Prondzynski, Elisabeth Krämer, Sandra D Laufer, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
April 29, 2017
Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae
Ingra Mannhardt, Alexandra Eder, Berengere Dumotier, et al.
Page
of 14